Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Horizon makes management appointments

This article was originally published in Scrip

Executive Summary

The US biopharmaceutical company Horizon Therapeutics has named Amy Grahn vice-president of clinical operations and Iain Duncan senior vice-president of operations. Ms Grahn was most recently vice-president of clinical operations at MedGenesis Therapeutix. Mr Duncan was a co-founder of Corus Pharma, which was bought by Gilead Sciences, and was most recently Corus's vice-president of operations.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts